Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Robert B. Jenkins is active.

Publication


Featured researches published by Robert B. Jenkins.


Cancer | 2003

Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features

Martin van den Bent; Leendert Looijenga; Karin Langenberg; Winand N.M. Dinjens; Wilfried W.J. Graveland; Ludo L. Uytdewilligen; Peter A. E. Sillevis Smitt; Robert B. Jenkins; Johan M. Kros

Patients who have oligodendrogliomas (OD) that demonstrate loss of both 1p and 19q appear to have a better prognosis after they receive chemotherapy and radiotherapy compared with patients who have OD without these characteristics. It is unclear whether this improvement in outcome is due only to a better response to treatment. The authors investigated the correlation between genetic and clinical characteristics of OD in 33 patients who received chemotherapy with procarbazine, lomustine, and vincristine for recurrent disease after receiving radiotherapy.


Genes, Chromosomes and Cancer | 1998

Fish mapping of YAC clones at human chromosomal band 7q31.2: identification of YACS spanning FRA7G within the common region of LOH in breast and prostate cancer.

Haojie Huang; Chiping Qian; Robert B. Jenkins; David I. Smith

Loss of DNA sequences within human chromosomal band 7q31.2 is frequently observed in a number of different solid tumors including breast, prostate, and ovarian cancer. This chromosomal band also contains the common fragile site, FRA7G. Many of the common fragile sites occur within chromosomal regions that are frequently deleted during tumor formation but their precise position, relative to the chromosome breakpoints and deletions, has not been defined for the majority of the fragile sites. Because the frequency of expression of FRA7G is low, we analyzed the expression of FRA7G in a chromosome 7‐only somatic cell hybrid (hamster‐human). YAC clones defining a contig spanning 7q31.2 were then used as FISH probes against metaphase spreads prepared from the hybrid cells after aphidicolin induction. This analysis quickly revealed whether a specific YAC clone mapped proximal, distal, or actually spanned the region of decondensation/breakage of FRA7G. By using this approach, we have identified several overlapping YAC clones that clearly span FRA7G. Interestingly, these clones map precisely to the common region of LOH in breast cancer and prostate cancer. In addition, the MET oncogene is contained within the three YACs that span FRA7G. Genes Chromosomes Cancer 21:152–159, 1998.


Archive | 1997

Cytogenetic Abnormalities Associated with Endocrine Neoplasia

Stefan K. Grebe; Norman L. Eberhardt; Robert B. Jenkins

During the past decade, cytogenetic studies of solid human neoplasms have come of age. Although technically more difficult and often ambiguous in comparison with cytogenetic studies of leukemias and lymphomas (1) cytogenetic studies of many solid tumors have yielded valuable insights into tumor pathogenesis and prognosis. In addition, in the last decade we have seen increasing application of molecular genetic techniques to the study of cancer, which has contributed greatly to our understanding of mechanisms controlling cell growth. Specific genetic alterations responsible for the pathogenesis of a number of neoplasms have been identified.


The Journal of Clinical Endocrinology and Metabolism | 1997

Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.

Stefan K. G. Grebe; Bryan McIver; Ian D. Hay; Patricia S.-C. Wu; Léa Maria Zanini Maciel; Harry A. Drabkin; John R. Goellner; Clive S. Grant; Robert B. Jenkins; Norman L. Eberhardt


Genomics | 1998

Genomic organization and mutation analysis of p73 in oligodendrogliomas with chromosome 1 p-arm deletions.

Ming Mai; Haojie Huang; Christopher Reed; Chiping Qian; Justin S. Smith; Benjamin Alderete; Robert B. Jenkins; David I. Smith; Wanguo Liu


Archive | 2000

Method and probe set for detecting cancer

Kevin C. Halling; Robert B. Jenkins; Walter King; Irina A. Sokolova; Steven A. Seelig


Journal of Neurosurgery | 1995

Use of fluorescence in situ hybridization to detect loss of chromosome 10 in astrocytomas

Stephen J. Dalrymple; John F. Herath; Steven R. Ritland; Cheryl A. Moertel; Robert B. Jenkins


Archive | 1999

METHODS AND PROBE SETS FOR DETERMINING PROSTATE CANCER PROGNOSIS

Robert B. Jenkins; Kazunari Sato; Junqi Qian


Archive | 2010

Peptide-mediated non-covalent delivery of active agents across the blood brain barrier

Geoffrey L. Curran; Gobinda Sarkar; Joseph F. Poduslo; Robert B. Jenkins; Val Lowe; Eric W. Mahlum


Archive | 2012

Peptide-mediated delivery of active agents across the blood-brain barrier

Gobinda Sarkar; Geoffry L. Curran; Robert B. Jenkins

Collaboration


Dive into the Robert B. Jenkins's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Elai Davicioni

University of Southern California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anirban P. Mitra

University of Southern California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Haojie Huang

University of Rochester

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge